Trends in hypertension control and left ventricular hypertrophy over three years

Italian Heart Journal

Volumn 3, Issue 9, 2002, Pages 514-519

  Cuspidi, Cesare ^a   Michev, Iassen ^a   Meani, Stefano ^a   Severgnini, Barbara ^a   Fusi, Veronica ^a   Salerno, Maurizio ^a   Valerio, Christiana ^a   Magrini, Fabio ^a   Zanchetti, Alberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Blood pressure; Hypertension; Hypertrophy; Left ventricular

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACCURACY; ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIAGNOSTIC TEST; ELECTRIC POTENTIAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITAL DEPARTMENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PHYSICAL EXAMINATION; PREVALENCE; REMISSION;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PREVALENCE;

EID: 0036758554     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol and stroke in Eastern Asia. Lancet 1998; 352: 1801-7.
2. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
3. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
4. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214-8.
5. Marques-Vidal P, Tuomiletho J. Hypertension awareness, treatment and control in the community: is the "rule of halves" still valid ? J Hum Hypertens 1997; 11: 213-20.
6. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood pressure control in the hypertensive population. Lancet 1997; 349: 454-7.
7. Isles CG, Walker LM, Beevers GD, et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986; 4: 141-56.
8. Lindholm L, Ejertsson G, Schersten B. High risk of cerebrovascular morbidity in well treated male hypertensives: a retrospective study of 40-59 year old hypertensives in a Swedish primary care district. Acta Med Scand 1984; 216: 251-9.
9. Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46.
10. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 152-83.
11. Cuspidi C, Lonati L, Sampieri L, et al. Blood pressure control in a hypertension hospital clinic. J Hypertens 1999; 17: 835-41.
12. Schillaci G, Verdecchia P, Borgioni C, et al. Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol 1994; 74: 714-9.
13. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the health examination surveys 1960-1991. Hypertension 1995; 26: 60-5.
14. Menotti A, Lanti M, Zanchetti A, et al. Impact of the Gubbio population study on community control of blood pressure and hypertension. J Hypertens 2001; 19: 843-50.
15. Colhoun HM, Doug W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England. J Hypertens 1998; 16: 747-52.
16. Hansson L, Llooyd A, Anderson P, Kopp Z. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press 2002; 11: 35-45.
17. Chatellier G, Menard J, Devries C, Plouin PF, Regoulet P, Corvol P. Blood pressure control in a hypertension center. J Hypertens 1987; 5 (Suppl 5): S47-S49.
18. Hansson L, Zanchetti A, Carruthers SG, et al. Effect of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-62.
19. Dahlof B, Devereux RB, Kjeldsen SE, et al, for the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003.
20. Mathew J, Sleight P, Lonn E, et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001; 104: 1615-21.
21. Zanchetti A. Contribution of fixed low-dose combinations to initial therapy in hypertension. Eur Heart J 1999; 1 (Suppl L): L5-L9.
22. Reims H, Fossum E, Kjeldsen SE, Julius S. Home blood pressure monitoring. Current knowledge and directions for future research. Blood Press 2001; 10: 271-87.
23. Meja AD, Egan BM, Schork NJ, Zweifler AJ. Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med 1990; 112: 270-7.
24. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 1998; 31: 383-90.
25. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995; 25: 417-23.
26. Cuspidi C, Lonati L, Sampieri L, et al. "To better know hypertension". Educational meetings for hypertensive patients. Blood Press 2000; 9: 255-9.